Prospective clinical cohort trial analyzing long-term results after allogeneic stem cell transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009683

Enrollment

100

Registered

2015-11-25

Start date

2016-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z94.80 Z94.81

Interventions

Group 1: Description of health status and quality of life as long-term result after allogeneic stem cell Transplantation, prevalence of long-term complications. Identification of risk factors for late

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - allogeneic stem cell transplantation in Greifswald for hematologic malignancy - at least 5 year survival after allogeneic stem cell transplantration - no clinical signs of relapse or progression - written informed consent

Exclusion criteria

Exclusion criteria: - none defined

Design outcomes

Primary

Measure	Time frame
Description of health status and quality of life as long-term results after allogeneic stem cell transplantation, prevalence of long-term complications	—

Secondary

Measure	Time frame
Identifying risk-factors for late complications after allogeneic stem cell transplantion, esp. urological complications	—

Countries

Germany

Contacts

Public ContactThomas Neumann

Universitätsmedizin Greifswald der Ernst-Moritz-Arndt Universität GreifswaldKlinik für Innere Medizin CHämatologie, Onkologie, Transplantationszentrum, Palliativmedizin

thomas.neumann@uni-greifswald.de+49-3834-86-22025

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026